Ten healthy subjects and 20 patients with macular disease were included in this study. Prior to study entry, a screening examination, with assessment of best corrected distance visual acuity, slit lamp biomicroscopy, fundoscopy, and optical coherence tomography (OCT; Spectralis, Heidelberg Engineering, Heidelberg, Germany) was performed. Men and women aged 18 years or older were recruited in the outpatients' department of the Department of Ophthalmology at the Hanusch Hospital, Vienna. To be included into the healthy subjects group, absence of any ocular pathology or any history of ophthalmological disease was mandatory. In the macular disease patient group, a significant macular disease such as geographic atrophy, drusen maculopathy, or epiretinal membrane had to be present. Patients with exudative age-related macular degeneration, cystoid macular edema, or diabetic macula edema were excluded from the study due to the possibility of short-term fluctuations of macular function within the study period. Presence of any kind of opacity of the ocular media which could have had interfered with the study relevant procedures excluded the respective subject from the study.
All study related documents were reviewed by the ethics committee of the city of Vienna and written informed consent was obtained in all subjects prior to study entry. The study procedures followed the guidelines of Good Clinical Practice and adhered to the Tenets of the Declaration of Helsinki.
After the study enrollment, three measurements with the MP3 were scheduled on three different days within 1 week. As recommended by Wong et al.
6 the baseline examination (test 1) was classified as the training measurement.